Ondine Biomedical Inc.

OBI.L · LSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents£9,767£2,981£13,125£30,365
Short-Term Investments£0£0£0£0
Receivables£513£326£182£248
Inventory£1,272£1,066£1,294£1,061
Other Curr. Assets£636£377£528£1,830
Total Curr. Assets£12,188£4,750£15,129£33,504
Property Plant & Equip (Net)£597£949£1,404£601
Goodwill£0£0£0£0
Intangibles£0£0£0£0
Long-Term Investments£0£0£0£0
Tax Assets£0£0£0£0
Other NC Assets£37£35£36£35
Total NC Assets£634£984£1,440£636
Other Assets£0£0£0£0
Total Assets£12,822£5,734£16,569£34,140
Liabilities
Payables£1,586£1,363£388£1,202
Short-Term Debt£168£382£359£645
Tax Payable£0£0£0£0
Deferred Revenue£0£0£0£0
Other Curr. Liab.£4,191£1,745£3,160£2,075
Total Curr. Liab.£5,945£3,490£3,907£3,922
LT Debt£0£159£537£94
Deferred Rev, NC£0£0£0£0
Deferred Tax Liab, NC£0£0£0£0
Other NC Liab.£0£0£481£467
Total NC Liab.£0£159£1,018£561
Other Liabilities£0£0£0£0
Cap. Leases£168£541£896£242
Total Liabilities£5,945£3,649£4,925£4,483
Equity
Pref Stock£0£0£0£0
Common Stock£262,599£239,647£235,042£235,037
Retained Earnings-£285,432-£266,334-£251,922-£232,544
AOCI£0£0£0£0
Other Equity£29,710£28,772£28,524£27,164
Total Equity£6,877£2,085£11,644£29,657
Supplemental Information
Minority Interest£0£0£0£0
Total Liab. & Tot. Equity£12,822£5,734£16,569£34,140
Net Debt-£9,599-£2,440-£12,229-£29,626